Renergen Limited, an investment holding company, engages in the alternative and renewable energy businesses in South Africa and sub-Saharan Africa. It operates through Tetra4 and Cryovation segments. The company explores for, develops, and sells liquefied natural gas and helium gas. It also develops Cryo-Vacc technology, which enables the transportation of vaccines and biologics at low temperature without any electrical power. Renergen Limited was founded in 2005 and is based in Sandton, South Africa. As of January 7, 2026, Renergen Limited operates as a subsidiary of ASP Isotopes Inc.
Frequently asked questions
What sector does Renergen Ltd. (REN) operate in?
Renergen Ltd. belongs to the Energy sector and operates in the Oil & Gas E&P industry.
What is Renergen Ltd. (REN) current stock price?
As of the latest data, Renergen Ltd. stock price is ZAR 9.20, with a previous close of ZAR 9.20.
What is Renergen Ltd. (REN) current market capitalization?
Renergen Ltd. market cap is approximately 1.43 billion.
What is Renergen Ltd. (REN) Earnings Per Share (EPS)?
The trailing EPS is -ZAR 2.05.
Does Renergen Ltd. (REN) pay dividends?
No. Renergen Ltd. does not pay a dividend.
What is Renergen Ltd. (REN) beta (volatility) score?
Renergen Ltd. has a beta of 1.123, meaning its volatility is roughly in line with the market.
